Welcome to our dedicated page for VTEX SEC filings (Ticker: VTEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how VTEX converts rising gross merchandise volume into subscription revenue isn’t simple—the company files under IFRS, mixes 20-F language with U.S. Form 4s, and discloses fast-moving international contracts. If you have ever searched for “VTEX SEC filings explained simply,” you already know the challenge.
Stock Titan turns that complexity into clarity. Our AI reads each 20-F, 6-K, 8-K, and proxy statement the moment it hits EDGAR, then delivers plain-English highlights—no jargon. Need to monitor VTEX insider trading Form 4 transactions or get a VTEX quarterly earnings report 10-Q filing equivalent from the latest 6-K? You’ll receive side-by-side metrics, trend graphs, and risk flags in seconds. Real-time alerts cover every VTEX Form 4 insider transactions real-time, while concise summaries answer common queries such as “understanding VTEX SEC documents with AI.”
Investors use these insights to:
- Spot founder and VTEX executive stock transactions Form 4 before price moves
- Compare regions and verticals with our VTEX earnings report filing analysis
- Review key pay packages via the latest VTEX proxy statement executive compensation
- See how new contracts appear in VTEX 8-K material events explained
- Digest the VTEX annual report 10-K simplified (20-F) without reading 200 pages
Whether you’re following margin trends or checking covenant compliance, Stock Titan’s AI-powered summaries, expert context, and real-time feeds let you act on VTEX disclosures the moment they’re filed.
VTEX Form 144 notice: The filer proposes to sell 4,500 shares of VTEX common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $18,630.00. The securities were acquired on 03/19/2019 through previously exercised stock options and were paid for in cash.
The filing shows the approximate date of sale as 09/16/2025 on the NYSE. Recent related transactions disclosed include multiple Rule 10b5-1 sales during July and August 2025 totaling 9,000 shares with gross proceeds reported for each sale.
Form 144 notice for VTEX (VTEX) indicates a proposed sale of 4,500 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $18,630.00 and an approximate sale date of 09/16/2025. The shares were acquired on 03/19/2019 by previously exercised stock options and paid in cash. The filing lists prior 10b5-1 plan sales by related parties totaling 9,000 shares in July and August 2025 with accompanying gross proceeds shown. The notice includes the standard Rule 144 representation about material nonpublic information and 10b5-1 plan adoption disclosure.
VTEX Form 144 summary reports a proposed sale of 65,489 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $282,257.59. The securities were acquired as Restricted Stock Units from the issuer on 10/25/2021 and the planned approximate sale date is shown as 08/11/2025 on the NYSE.
The filing also lists 14 prior trades executed under a 10b5-1 plan between 05/12/2025 and 08/06/2025, totaling 104,426 shares sold, and shows 103,947,244 shares outstanding. The filer certifies they do not possess undisclosed material adverse information at the plan adoption or instruction date.
VTEX filed a Form 144 notifying the market of a proposed sale of 65,489 common shares with an aggregate market value of $282,257.59. The sale is scheduled to occur on 08/11/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The filing shows these shares were originally acquired as founders shares on 10/25/2019 and reports the issuer has 103,947,244 shares outstanding, making this a disclosure of an insider sale.
The Form also lists multiple recent 10b5-1 sales by "SIGNO INV TECH CO LTD" between May and August 2025 (including sales of 100; 6,250; and several 8,173-share transactions), indicating ongoing plan-based dispositions. The filing does not provide a date for adoption of any 10b5-1 plan or a stated reason for the proposed sale.
FAQ
What is the current stock price of VTEX (VTEX)?
What is the market cap of VTEX (VTEX)?
